Peptomyc
PrivateLast Round
VC Round
Mar 24, 2024
Total Funding Raised
$24.69M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Peptomyc is a biotechnology company developing a new generation of cell-penetrating peptide therapeutics targeting the MYC oncogene for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptomyc Comparables
Compare Peptomyc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incurix | 77% | |
| Omega Therapeutics | 77% | |
| Racura Oncology Ltd | 77% |
Peptomyc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2024 | ||||
| Grant | Oct 31, 2023 | ||||
| Convertible Debt | Jan 20, 2022 | ||||
| VC Round | Dec 15, 2020 | ||||
| Series A | Sep 12, 2019 | ||||
Grant | Jul 30, 2019 |
Key People
Founding team and executive leadership
Peptomyc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Convertible Debt |
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | VC Round, Grant |
| Alta Life Sciences | Convertible Debt, VC Round, Series A |
| Healthequity SCR | Convertible Debt, VC Round, Series A, Seed |
| Agencia Estatal de Investigación | Debt |
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 41% MoM.
- Jul 26, 2026
Monthly visitors increased 39% MoM.
Recent news
Latest coverage and updates
- hiresJul 3, 2026
Peptomyc SL hired Stephan Braun as Chief Medical Officer on Jul 3rd '26.
Peptomyc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Peptomyc's valuation, stock price, and market status.
Is Peptomyc a public or private company?
Peptomyc is a private company.
What is the current stock price of Peptomyc?
Peptomyc is a private company with no public stock price. No recent secondary market data is available.
How much is Peptomyc worth (valuation)?
Valuation information for Peptomyc is not publicly available.
Can I buy Peptomyc stock?
Peptomyc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Peptomyc's last funding round?
Peptomyc's most recent funding round was VC Round on March 24, 2024.
Who are the main investors in Peptomyc?
Key investors in Peptomyc include Horizon 2020, European Innovation Council, Alta Life Sciences, Healthequity SCR, EIT Health.
Will Peptomyc IPO soon?
No public IPO plans have been announced for Peptomyc.
How can I track Peptomyc secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Peptomyc's secondary market activity and sign up for updates.